Héroux-Devtek Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Héroux-Devtek de 28.2% y 6% respectivamente, mientras que el BPA crecerá en un 28.4% al año.

Información clave

28.2%

Tasa de crecimiento de los beneficios

28.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Aerospace & Defense	29.5%
Tasa de crecimiento de los ingresos	6.0%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	19 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Results: Héroux-Devtek Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 10

Recent updates

Results: Héroux-Devtek Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 10

Results: Héroux-Devtek Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 18

Previsiones de crecimiento de beneficios e ingresos

TSX:HRX - Estimaciones futuras de los analistas y datos financieros pasados (CAD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	697	N/A	47	79	1
3/31/2026	706	46	44	68	4
3/31/2025	661	36	38	53	5
3/31/2024	618	28	-35	-4	5
12/31/2023	602	24	-51	-12	N/A
9/30/2023	579	17	-49	-18	N/A
6/30/2023	570	17	-27	6	N/A
3/31/2023	544	14	-2	30	N/A
12/31/2022	535	19	11	36	N/A
9/30/2022	525	24	23	48	N/A
6/30/2022	524	27	33	56	N/A
3/31/2022	536	33	43	63	N/A
12/31/2021	544	30	62	85	N/A
9/30/2021	563	32	69	94	N/A
6/30/2021	569	28	71	93	N/A
3/31/2021	571	20	67	89	N/A
12/31/2020	582	-61	61	84	N/A
9/30/2020	589	-61	48	67	N/A
6/30/2020	598	-58	42	64	N/A
3/31/2020	613	-50	30	53	N/A
12/31/2019	604	34	46	63	N/A
9/30/2019	591	33	51	66	N/A
6/30/2019	542	29	52	65	N/A
3/31/2019	484	26	59	70	N/A
12/31/2018	439	20	48	51	N/A
9/30/2018	391	13	53	58	N/A
6/30/2018	385	13	58	62	N/A
3/31/2018	387	14	51	56	N/A
12/31/2017	394	17	53	67	N/A
9/30/2017	396	24	N/A	63	N/A
6/30/2017	398	31	N/A	53	N/A
3/31/2017	407	32	N/A	56	N/A
12/31/2016	403	32	N/A	28	N/A
9/30/2016	401	31	N/A	23	N/A
6/30/2016	404	27	N/A	20	N/A
3/31/2016	407	27	N/A	7	N/A
12/31/2015	395	16	N/A	23	N/A
9/30/2015	387	7	N/A	20	N/A
6/30/2015	377	4	N/A	32	N/A
3/31/2015	365	3	N/A	46	N/A
12/31/2014	350	6	N/A	47	N/A
9/30/2014	323	11	N/A	43	N/A
6/30/2014	295	10	N/A	31	N/A
3/31/2014	272	9	N/A	26	N/A
12/31/2013	255	13	N/A	18	N/A
9/30/2013	255	13	N/A	21	N/A
6/30/2013	256	13	N/A	19	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (28.2% al año) de HRX es superior a la tasa de ahorro (2%).

Beneficios vs. Mercado: Se prevé que los beneficios (28.2% al año) de HRX crezcan más rápidamente que el mercado Canadian (12.1% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de HRX crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (6% al año) de HRX crezcan más despacio que el mercado de Canadian (6.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 6% al año) de HRX crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de HRX se prevé que sea elevada dentro de 3 años.

Héroux-Devtek Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 7.5% to CA$24.50

Results: Héroux-Devtek Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Consensus EPS estimates increase by 26%

Price target increased by 7.3% to CA$20.70

Consensus EPS estimates fall by 40%

Consensus EPS estimates fall by 42%

Recent updates

Héroux-Devtek Inc. to Report Q4, 2024 Results on May 22, 2024

Price target increased by 7.5% to CA$24.50

Results: Héroux-Devtek Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Is Now The Time To Look At Buying Héroux-Devtek Inc. (TSE:HRX)?

Consensus EPS estimates increase by 26%

Price target increased by 7.3% to CA$20.70

Héroux-Devtek Inc. to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Héroux-Devtek Inc. to Report Q2, 2024 Results on Nov 10, 2023

New major risk - Financial position

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

Héroux-Devtek Inc., Annual General Meeting, Aug 08, 2023

Now 20% undervalued

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 40%

Third quarter 2023 earnings: Revenues in line with analyst expectations

Consensus EPS estimates fall by 42%

At CA$16.20, Is Héroux-Devtek Inc. (TSE:HRX) Worth Looking At Closely?

Investor sentiment improves as stock rises 16%

Héroux-Devtek Inc. to Report Q3, 2023 Results on Feb 08, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Héroux-Devtek Inc. to Report Q2, 2023 Results on Nov 11, 2022

Consensus EPS estimates fall by 28%

Price target decreased to CA$21.80

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Héroux-Devtek Inc. to Report Q1, 2023 Results on Aug 05, 2022

Insider exercised options to buy CA$74k worth of stock.

CFO & VP recently sold CA$383k worth of stock

Héroux-Devtek Inc., Annual General Meeting, Aug 05, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 13%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 23% undervalued after recent price drop

President exercised options to buy CA$568k worth of stock.

Second quarter 2022 earnings released: EPS CA$0.21 (vs CA$0.11 in 2Q 2021)

Executive Chairman of the Board exercised options to buy CA$325k worth of stock.

First quarter 2022 earnings released: EPS CA$0.19 (vs CA$0.038 loss in 1Q 2021)

President exercised options to buy CA$188k worth of stock.

Is It Time To Consider Buying Héroux-Devtek Inc. (TSE:HRX)?

We Like Héroux-Devtek's (TSE:HRX) Earnings For More Than Just Statutory Profit

Full year 2021 earnings released: EPS CA$0.55 (vs CA$1.38 loss in FY 2020)

Price target increased to CA$22.00

Calculating The Fair Value Of Héroux-Devtek Inc. (TSE:HRX)

Is Héroux-Devtek (TSE:HRX) Using Too Much Debt?

New 90-day high: CA$16.46

Our Take On The Returns On Capital At Héroux-Devtek (TSE:HRX)

This Insider Has Just Sold Shares In Héroux-Devtek Inc. (TSE:HRX)

Héroux-Devtek Inc. Appoints Didier Evrard as Director

Third quarter 2021 earnings released: EPS CA$0.24 (vs CA$0.24 in 3Q 2020)

Revenue and earnings beat expectations

Price target raised to CA$18.83

New 90-day high: CA$15.40

Is There Now An Opportunity In Héroux-Devtek Inc. (TSE:HRX)?

A Look At The Intrinsic Value Of Héroux-Devtek Inc. (TSE:HRX)

Héroux-Devtek Inc. to Report Q3, 2021 Results on Feb 05, 2021

New 90-day high: CA$14.94

A Look At Héroux-Devtek's (TSE:HRX) Share Price Returns

What You Need To Know About Héroux-Devtek Inc.'s (TSE:HRX) Investor Composition

How Much Are Héroux-Devtek Inc. (TSE:HRX) Insiders Spending On Buying Shares?

Results: Héroux-Devtek Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Price target raised to CA$16.33

Revenue and earnings beat expectations

New 90-day high: CA$12.29

Héroux-Devtek Inc. to Report Q2, 2021 Results on Nov 13, 2020

Héroux-Devtek Inc.'s CESA subsidiary in Spain Receives Major Multi-Year Supply Agreement with Boeing for the Manufacture of Several Actuation Components

New 90-day low: CA$9.24